Treatment of NSCLC cell lines with Pirfenidone caused significant reduction in total SMAD3 in the A549, H1650, H1975, and H520 cell lines and a similar trend in H838 (Figure 2B) were observed. This evidence concerns the gene SMAD3 and non-small cell lung carcinoma.